WindRose Health Investors Completes the Sale of Vital Decisions to Evolent Health
Retrieved on:
Wednesday, October 6, 2021
EVH, Goal, Partnership, Palliative care, Quality assurance, Solution, Accreditation, Sale, Health, McDermott Will & Emery, Patient, Company, LLC, Life, Windrose, Entrepreneurship, Beijing New Century International Hospital for Children, Investment, Quality of life, NYSE, National Committee, Education, Medical device, Medicine
NEW YORK, Oct. 6, 2021 /PRNewswire/ -- WindRose Health Investors, LLC ("WindRose"), the New York-based healthcare private equity firm, announced today that it has completed the sale of Vital Decisions, LLC ("Vital Decisions" or the "Company") to Evolent Health, Inc. ("Evolent Health").
Key Points:
- NEW YORK, Oct. 6, 2021 /PRNewswire/ -- WindRose Health Investors, LLC ("WindRose"), the New York-based healthcare private equity firm, announced today that it has completed the sale of Vital Decisions, LLC ("Vital Decisions" or the "Company") to Evolent Health, Inc. ("Evolent Health").
- Vital Decisions will report into Evolent's specialty management offering, New Century Health, and will be consolidated into Evolent's Clinical Solutions segment.
- WindRose Health Investors, LLC ("WindRose") makes equity investments in companies that operate within the services sectors of the healthcare industry.
- Evolent Health (NYSE: EVH) delivers proven clinical and administrative solutions that improve whole-person health while making health care simpler and more affordable.